Analysis Of Income And Expense [Abstract]

Biotage - Filing #702086

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
1 232 SEK
1 092 SEK
Material income and expense [abstract]
Research and development expense
9 1 SEK
7 2 SEK
Finance income (cost)
2,000,000 SEK
17,000,000 SEK
Selling, general and administrative expense [abstract]
Selling expense
2 8 7 SEK
2 7 0 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- SEK
- SEK
67,000,000 SEK
- SEK
272,000,000 SEK
205,000,000 SEK
175,000,000 SEK
- SEK
113,000,000 SEK
62,000,000 SEK
0 SEK
- SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
272,000,000 SEK
113,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.